GlassScriptPhysician profile
Maryellen Blank
NPI 1609930015
$9,002.89
in general payments reported to CMS, 2019-2025
14 companies · $4,777 in 2025
The $4,777 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $565 · 2024: $3,661 · 2025: $4,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,854 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,854.06 |
| Education | $148.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,640.25 | 2023-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,551.22 | 2023-2025 | Caplyta |
| Alkermes, INC. | $1,312.48 | 2024-2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $1,143.54 | 2023-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $757.32 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $592.23 | 2024-2025 | Cobenfy |
| Abbvie INC. | $448.07 | 2024-2025 | |
| Axsome Therapeutics, INC. | $432.23 | 2024-2025 | Auvelity |
| Lundbeck LLC | $414.84 | 2023-2025 | Abilify Maintena, Rexulti |
| Janssen Pharmaceuticals, INC | $318.61 | 2023-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Vanda Pharmaceuticals INC. | $223.86 | 2024-2025 | Fanapt, Hetlioz |
| Corium, LLC | $86.52 | 2024-2025 | Azstarys |
| Indivior INC. | $59.93 | 2023-2024 | Perseris |
| Luye Pharma (USA) LTD. | $21.79 | 2025 | Erzofri Extended-Release |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryellen Blank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.